Open | 6.98 |
Previous Close | 6.85 |
Day Range | 6.98 - 7.41 |
52-Week Range | 5.99 - 22.47 |
All-Time High | 22,031.71 |
Avg. Volume (50-day) | 70,411.08 |
EPS (TTM) | -161.42 |
Next Earnings Date | 2024-11-07 |
Last Earnings Date | 2024-08-12 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | -0.04 |
PEG Ratio | - |
Price to Book | 0.54 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 0.44 M |
Revenue per Share (TTM) | 0.04 |
Shares Outstanding | 10.672 M |
Share Float (%) | 8.57 M |
% Held by Institutions | 56.98 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 7.75 (-5.94%) |
+/- SMA(50) | 7.64 (-4.58%) |
+/- SMA(200) | 9.68 (-24.69%) |
5-Day Perf. | -12.8% |
1-Month Perf. | -0.27% |
3-Month Perf. | -13.52% |
6-Month Perf. | -28.53% |
YTD Perf. | -1.88% |
1-Year Perf. | -51.91% |
RSI(14) | 44.53 |
ATR(14) | 0.92 |
ADX(14) | 33.01 |
Beta (5Y) | 1.19 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.
AVTX has triggered the following predefined scans:
New CCI Sell Signals |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.